Nobuhiro Kanaji

1.7k total citations
80 papers, 1.2k citations indexed

About

Nobuhiro Kanaji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nobuhiro Kanaji has authored 80 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 16 papers in Surgery. Recurrent topics in Nobuhiro Kanaji's work include Lung Cancer Treatments and Mutations (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Medical Imaging and Pathology Studies (11 papers). Nobuhiro Kanaji is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Medical Imaging and Pathology Studies (11 papers). Nobuhiro Kanaji collaborates with scholars based in Japan, United States and Germany. Nobuhiro Kanaji's co-authors include Shuji Bandoh, Norimitsu Kadowaki, Tomoya Ishii, Reiji Haba, Naoki Watanabe, Amy Nelson, Joel Michalski, Xiangde Liu, Xingqi Wang and Masanori Nakanishi and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Nobuhiro Kanaji

76 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nobuhiro Kanaji

Since Specialization

Citations

This map shows the geographic impact of Nobuhiro Kanaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Kanaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Kanaji more than expected).

Fields of papers citing papers by Nobuhiro Kanaji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Kanaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Kanaji. The network helps show where Nobuhiro Kanaji may publish in the future.

Co-authorship network of co-authors of Nobuhiro Kanaji

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Kanaji. A scholar is included among the top collaborators of Nobuhiro Kanaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Kanaji. Nobuhiro Kanaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells 2025 ·Cancers ·Takuya Inoue, Nobuhiro Kanaji, Takafumi Nakamura, Masanao Yokohira, Y. Komori, (unknown), (unknown), Naoki Watanabe, Norimitsu Kadowaki	0
2	Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease 2025 ·Journal of Personalized Medicine ·Nobuhiro Kanaji, Naoki Watanabe, Takuya Inoue, (unknown), (unknown), (unknown), Norimitsu Kadowaki	1
3	Efficacy of immune checkpoint inhibitors according to programmed cell death‐ligand 1 expression in patients with non‐small cell lung cancer and brain metastasis: A real‐world prospective observational study 2024 ·Thoracic Cancer ·Takeshi Masuda, (unknown), K. Hata, (unknown), Katsuyuki Kiura, Nobuhiro Kanaji, Takuya Inoue, Masahiro Kodani, Masaaki Yanai, Kakuhiro Yamaguchi, (unknown), Masahiro Yamasaki, Nobuhisa Ishikawa, Ken Masuda, (unknown), Shoichi Kuyama, Tetsuya Kubota, Kazuya Nishii, Katsuyuki Hotta, Noboru Hattori	2
4	Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005) 2024 ·Lung ·Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, Takashi Ninomiya, Toshiyuki Kozuki, Nobuhisa Ishikawa, Kazuya Nishii, (unknown), Kakuhiro Yamaguchi, (unknown), Yuko Toyoda, Masaaki Inoue, Nobuyuki Miyatake, Naoki Watanabe, Takuya Inoue, (unknown), (unknown), (unknown), Norimitsu Kadowaki	5
5	FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma 2023 ·Scientific Reports ·(unknown), Takashi Norikane, (unknown), Yuka Yamamoto, (unknown), (unknown), Makiko Murota, Nobuhiro Kanaji, Yoshihiro Nishiyama	1
6	First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study 2022 ·Journal of Cancer Research and Clinical Oncology ·Kenichiro Kudo, Kazuya Nishii, Go Makimoto, Nobuhisa Ishikawa, Yukari Tsubata, Masahiro Kodani, Nobukazu Fujimoto, Masahiro Yamasaki, Tetsuya Kubota, Nagio Takigawa, Kazunori Fujitaka, Nobuhiro Kanaji, Takuo Shibayama, (unknown), (unknown), Katsuyuki Hotta, Katsuyuki Kiura	6
7	Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients 2019 ·The Open Respiratory Medicine Journal ·Nobuhiro Kanaji, Kyuichi Kadota, (unknown), Takuya Inoue, Naoki Watanabe, Reiji Haba, Norimitsu Kadowaki, Tomoya Ishii	4
8	Characteristics of multiple nodules in a patient with pulmonary Langerhans cell histiocytosis: A case report 2019 ·World Journal of Clinical Cases ·Nobuhiro Kanaji, (unknown), Ryou Ishikawa, Naoki Watanabe, Norimitsu Kadowaki	2
9	Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation 2018 ·Therapeutics and Clinical Risk Management ·Nobuhiro Kanaji, (unknown), Takuya Inoue, (unknown), Naoki Watanabe, Tomoya Ishii, Yasunori Tojo, Masahiro Yamaguchi, Norimitsu Kadowaki	13
10	The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions 2018 ·BMC Pulmonary Medicine ·Naoki Watanabe, Tomoya Ishii, Nobuyuki Kita, Nobuhiro Kanaji, Hiroyuki Nakamura, (unknown), Yutaka Ueda, Yasunori Tojo, Norimitsu Kadowaki, Shuji Bandoh	15
11	Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report 2017 ·BMC Infectious Diseases ·Naoki Watanabe, Kiyofumi Ohkusu, (unknown), Osamu Imataki, Tomoya Ishii, Kiyoshi Negayama, (unknown), Nobuyuki Kita, Takehiro Takagi, Nobuhiro Kanaji, Norimitsu Kadowaki, Shuji Bandoh	6
12	Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells 2017 ·Anticancer Research ·Nobuhiro Kanaji, Nobuyuki Kita, Norimitsu Kadowaki, Shuji Bandoh	9
13	Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease 2017 ·Lung Cancer ·Nobuhiro Kanaji, Kenichiro Sakai, Yutaka Ueda, Hiroshi Miyawaki, Tomoya Ishii, Naoki Watanabe, Nobuyuki Kita, Kyuichi Kadota, Norimitsu Kadowaki, Shuji Bandoh	20
14	Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta 2016 ·Experimental Lung Research ·(unknown), Nobuhiro Kanaji, (unknown), (unknown), Norimitsu Kadowaki, Shuji Bandoh	12
15	Attenuation of Inhibitory Prostaglandin E2 Signaling in Human Lung Fibroblasts Is Mediated by Phosphodiesterase 4 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Joel Michalski, Nobuhiro Kanaji, Xiangde Liu, (unknown), Xingqi Wang, Hesham Basma, Masanori Nakanishi, Tadashi Sato, (unknown), (unknown), Amy Nelson, (unknown), Olaf Holz, H Magnussen, Klaus F. Rabe, Myron L. Toews, Stephen I. Rennard	10
16	Differential Roles of JNK, ERK1/2, and p38 Mitogen-Activated Protein Kinases on Endothelial Cell Tissue Repair Functions in Response to Tumor Necrosis Factor-α 2012 ·Journal of Vascular Research ·Nobuhiro Kanaji, Amy Nelson, Xingqi Wang, Tadashi Sato, Masanori Nakanishi, (unknown), Hesham Basma, Joel Michalski, Maha Farid, Stephen I. Rennard, Xiangde Liu	18
17	Prostaglandin E2 Stimulates the Production of Vascular Endothelial Growth Factor through the E-Prostanoid–2 Receptor in Cultured Human Lung Fibroblasts 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Masanori Nakanishi, Tadashi Sato, (unknown), Amy Nelson, Maha Farid, Joel Michalski, Nobuhiro Kanaji, Xingqi Wang, Hesham Basma, Amol Patil, (unknown), Xiangde Liu, Shinsaku Togo, Myron L. Toews, Olaf Holz, (unknown), H Magnussen, Stephen I. Rennard	22
18	IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells 2011 ·Journal of Allergy and Clinical Immunology ·Tadashi Sato, Xiangde Liu, Hesham Basma, Shinsaku Togo, Hisatoshi Sugiura, Amy Nelson, Masanori Nakanishi, Nobuhiro Kanaji, Xingqi Wang, Mi‐Ok Kim, Yingji Li, Joel Michalski, Maha Farid, John Sharp, Stephen I. Rennard	8
19	Cytokeratins negatively regulate the invasive potential of lung cancer cell lines 2011 ·Oncology Reports ·Nobuhiro Kanaji	17
20	Reduced miR-146a Increases Prostaglandin E2 in Chronic Obstructive Pulmonary Disease Fibroblasts 2010 ·American Journal of Respiratory and Critical Care Medicine ·Tadashi Sato, Xiangde Liu, Amy Nelson, Masanori Nakanishi, Nobuhiro Kanaji, Xingqi Wang, Mi‐Ok Kim, Yingji Li, Jianhong Sun, Joel Michalski, Amol Patil, Hesham Basma, Olaf Holz, H Magnussen, Stephen I. Rennard	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact